Found: 117
Select item for more details and to access through your institution.
Early onset of cardiomyopathy and intellectual disability in a girl with Danon disease associated with a de novo novel mutation of the LAMP2 gene.
- Published in:
- Neuropathology, 2016, v. 36, n. 6, p. 561, doi. 10.1111/neup.12307
- By:
- Publication type:
- Article
Anti-Factor V inhibitor in patients with autoimmune diseases: case report and literature review.
- Published in:
- International Medical Case Reports Journal, 2011, v. 4, p. 31, doi. 10.2147/IMCRJ.S19433
- By:
- Publication type:
- Article
Clinical utility and impact of the use of the chromogenic vs one‐stage factor activity assays in haemophilia A and B.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 1, p. 3, doi. 10.1111/ejh.13339
- By:
- Publication type:
- Article
Association between heaviness of cigarette smoking and serious psychological distress is stronger in women than in men: a nationally representative cross-sectional survey in Japan.
- Published in:
- Harm Reduction Journal, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12954-021-00469-5
- By:
- Publication type:
- Article
Occupational status and self-reported low back pain by gender: a nation-wide cross-sectional study among the general population in Japan.
- Published in:
- Environmental Health & Preventive Medicine, 2021, v. 26, n. 1, p. 1, doi. 10.1186/s12199-021-01031-2
- By:
- Publication type:
- Article
Correlations between global clotting function tests, duration of operation, and postoperative chest tube drainage in pediatric cardiac surgery.
- Published in:
- Pediatric Anesthesia, 2011, v. 21, n. 8, p. 865, doi. 10.1111/j.1460-9592.2011.03524.x
- By:
- Publication type:
- Article
Force‐sensing treadmill gait analysis system can detect gait abnormalities in haemophilia patients without arthropathy.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 780, doi. 10.1111/hae.14987
- By:
- Publication type:
- Article
Association of patient, treatment and disease characteristics with patient‐reported outcomes: Results of the ECHO Registry.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 106, doi. 10.1111/hae.14895
- By:
- Publication type:
- Article
Anti‐idiotype monoclonal antibodies against emicizumab enable accurate procoagulant and anticoagulant assays, irrespective of the test base, in the presence of emicizumab.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 329, doi. 10.1111/hae.14662
- By:
- Publication type:
- Article
Emicizumab enhances thrombus formation in vitro under high shear flow conditions in whole blood from patients with type 1 and type 3 von Willebrand disease.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. 694, doi. 10.1111/hae.14581
- By:
- Publication type:
- Article
The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 854, doi. 10.1111/hae.14363
- By:
- Publication type:
- Article
Emicizumab improves thrombus formation of type 2A von willebrand disease under high shear condition.
- Published in:
- Haemophilia, 2021, v. 27, n. 2, p. e194, doi. 10.1111/hae.14272
- By:
- Publication type:
- Article
Substitution therapy.
- Published in:
- Haemophilia, 2021, v. 27, p. 53, doi. 10.1111/hae.14072
- By:
- Publication type:
- Article
Long‐term safety and efficacy of emicizumab for up to 5.8 years and patients' perceptions of symptoms and daily life: A phase 1/2 study in patients with severe haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 1, p. 81, doi. 10.1111/hae.14205
- By:
- Publication type:
- Article
Health‐related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors—Results from the HAVEN 2 study.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 1009, doi. 10.1111/hae.14183
- By:
- Publication type:
- Article
Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 966, doi. 10.1111/hae.14144
- By:
- Publication type:
- Article
Emicizumab improves the stability and structure of fibrin clot derived from factor VIII‐deficient plasma, similar to the addition of factor VIII.
- Published in:
- Haemophilia, 2020, v. 26, n. 3, p. e97, doi. 10.1111/hae.13961
- By:
- Publication type:
- Article
Assessment of self‐/parent‐reported quality of life in Japanese children with haemophilia using the Japanese version of KIDSCREEN‐52.
- Published in:
- Haemophilia, 2020, v. 26, n. 2, p. 243, doi. 10.1111/hae.13945
- By:
- Publication type:
- Article
A multicentre, open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors.
- Published in:
- Haemophilia, 2019, v. 25, n. 6, p. 979, doi. 10.1111/hae.13848
- By:
- Publication type:
- Article
Health‐related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non‐interventional study (NIS).
- Published in:
- Haemophilia, 2019, v. 25, n. 3, p. 382, doi. 10.1111/hae.13731
- By:
- Publication type:
- Article
Whole blood ristocetin‐induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease.
- Published in:
- Haemophilia, 2019, v. 25, n. 3, p. e174, doi. 10.1111/hae.13725
- By:
- Publication type:
- Article
Once‐weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8‐GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial).
- Published in:
- Haemophilia, 2019, v. 25, n. 3, p. 373, doi. 10.1111/hae.13712
- By:
- Publication type:
- Article
Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non‐interventional study in a real‐world setting.
- Published in:
- Haemophilia, 2019, v. 25, n. 2, p. 213, doi. 10.1111/hae.13655
- By:
- Publication type:
- Article
A case of moderate haemophilia A with inhibitor, carrying the p.R1800H mutation, complicated with juvenile idiopathic arthritis.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
The effect of emicizumab prophylaxis on health‐related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study.
- Published in:
- Haemophilia, 2019, v. 25, n. 1, p. 33, doi. 10.1111/hae.13618
- By:
- Publication type:
- Article
Bleeding events and safety outcomes in persons with haemophilia A with inhibitors: A prospective, multi‐centre, non‐interventional study.
- Published in:
- Haemophilia, 2018, v. 24, n. 6, p. 921, doi. 10.1111/hae.13612
- By:
- Publication type:
- Article
Mental component of health-related quality of life is an independent predictor of incident functional disability among community-dwelling older people: a prospective cohort study.
- Published in:
- Quality of Life Research, 2021, v. 30, n. 7, p. 1853, doi. 10.1007/s11136-021-02780-x
- By:
- Publication type:
- Article
Von Willebrand factor protects the Ca<sup>2+</sup>-dependent structure of the factor VIII light chain.
- Published in:
- British Journal of Haematology, 2009, v. 146, n. 5, p. 531, doi. 10.1111/j.1365-2141.2009.07792.x
- By:
- Publication type:
- Article
Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 3, p. 409, doi. 10.1111/j.1365-2141.2008.07366.x
- By:
- Publication type:
- Article
Selective factor VIII and V inactivation by iminodiacetate ion exchange resin through metal ion adsorption.
- Published in:
- British Journal of Haematology, 2008, v. 142, n. 6, p. 962, doi. 10.1111/j.1365-2141.2008.07289.x
- By:
- Publication type:
- Article
Identification of a thrombin-interactive site within the FVIII A2 domain that is responsible for the cleavage at Arg<sup>372</sup>.
- Published in:
- British Journal of Haematology, 2008, v. 140, n. 4, p. 433, doi. 10.1111/j.1365-2141.2007.06935.x
- By:
- Publication type:
- Article
Anticoagulant effects of a synthetic peptide containing residues Thr-2253–Gln-2270 within factor VIII C2 domain that selectively inhibits factor Xa-catalysed factor VIII activation.
- Published in:
- British Journal of Haematology, 2002, v. 116, n. 4, p. 868, doi. 10.1046/j.0007-1048.2002.03360.x
- By:
- Publication type:
- Article
Fraction and Number of Unemployed Associated with Self-Reported Low Back Pain: A Nation-Wide Cross-Sectional Study in Japan.
- Published in:
- International Journal of Environmental Research & Public Health, 2021, v. 18, n. 20, p. 10760, doi. 10.3390/ijerph182010760
- By:
- Publication type:
- Article
Thyroid function in patients with selenium deficiency exhibits high free T4 to T3 ratio.
- Published in:
- Clinical Pediatric Endocrinology, 2021, v. 30, n. 1, p. 19, doi. 10.1297/cpe.30.19
- By:
- Publication type:
- Article
Hemostatic Treatment Using Factor VIII Concentrates for Neutralizing High-Responding Inhibitors Prior to CVAD Insertion for Immune-Tolerance Induction Therapy.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2012, v. 18, n. 1, p. 66, doi. 10.1177/1076029611412364
- By:
- Publication type:
- Article
Functional life-long maintenance of engineered liver tissue in mice following transplantation under the kidney capsule.
- Published in:
- Journal of Tissue Engineering & Regenerative Medicine, 2010, v. 4, n. 2, p. 141, doi. 10.1002/term.225
- By:
- Publication type:
- Article
Delivery of Full-Length Factor VIII Using a <i>piggyBac</i> Transposon Vector to Correct a Mouse Model of Hemophilia A.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104957
- By:
- Publication type:
- Article
A Novel Cell-Sheet Technology That Achieves Durable Factor VIII Delivery in a Mouse Model of Hemophilia A.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0083280
- By:
- Publication type:
- Article
Current and future therapies for haemophilia—Beyond factor replacement therapies.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 23, doi. 10.1111/bjh.18379
- By:
- Publication type:
- Article
Prediction of the haemostatic effects of bypassing therapy using comprehensive coagulation assays in emicizumab prophylaxis‐treated haemophilia A patients with inhibitors.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 5, p. 727, doi. 10.1111/bjh.16574
- By:
- Publication type:
- Article
A novel simultaneous clot‐fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 4, p. 518, doi. 10.1111/bjh.16111
- By:
- Publication type:
- Article
Emicizumab‐mediated haemostatic function in patients with haemophilia A is down‐regulated by activated protein C through inactivation of activated factor V.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 2, p. 257, doi. 10.1111/bjh.15525
- By:
- Publication type:
- Article
Factor (F)VIII/VIIa enhances global haemostatic function in the co-presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 528, doi. 10.1111/bjh.15209
- By:
- Publication type:
- Article
Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 5, p. 813, doi. 10.1111/bjh.13757
- By:
- Publication type:
- Article
Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 1, p. 104, doi. 10.1111/bjh.12473
- By:
- Publication type:
- Article
Heterogeneous coagulant potential of emicizumab in neonatal factor VIII–deficient plasma.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 7, p. 1, doi. 10.1002/pbc.29731
- By:
- Publication type:
- Article
Outcomes in children with hemophilia A with inhibitors: Results from a noninterventional study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Disordered hemostasis associated with severely depressed fibrinolysis demonstrated using a simultaneous thrombin and plasmin generation assay during L-asparaginase induction therapy in pediatric acute lymphoblastic leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The use of infrared thermography for non-invasive detection of bleeding and musculoskeletal abnormalities in patients with hemophilia: an observational study.
- Published in:
- Thrombosis Journal, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12959-023-00511-5
- By:
- Publication type:
- Article
Successful unrelated cord blood transplantation for Diamond–Blackfan anemia.
- Published in:
- 2021
- By:
- Publication type:
- Case Study